Business Context and Reporting Period
Creative Medical Technology Holdings, Inc. (CELZ), a Nevada corporation, filed this Form 8-K on June 9, 2023. The report details a material modification to the rights of security holders and amendments to the Articles of Incorporation.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and capital structure adjustments.
Material Changes
- Reverse Stock Split: The Company implemented a 1-for-10 reverse stock split of its Common Stock.
- Effective Date: The split became effective on the Nasdaq Capital Market at the open of business on June 12, 2023.
- Authorized Shares: The authorized number of Common Stock shares was reduced from 50 million to 5 million.
- Shareholder Impact: Share counts were divided by 10 and rounded up to the next whole number. No fractional shares or cash payments were issued; holders of fractional amounts received one whole share.
- Ownership: Percentage ownership and voting power remain unchanged, barring minor rounding adjustments.
- Identification: The CUSIP number for the Common Stock changed to 22529Y 408.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future financial guidance, operational outlook, or specific risk factors. The primary purpose is to disclose the execution of the reverse stock split and the associated reduction in authorized shares.
Investor Verification Checklist
- Verify the new CUSIP number (22529Y 408) for trading purposes.
- Confirm the adjusted share count in brokerage accounts following the June 12, 2023 effective date.
- Review the reduction in authorized shares from 50 million to 5 million.
- Check for any subsequent filings regarding the Company's compliance with Nasdaq listing standards post-split.